Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease
The Obstetrician & Gynaecologist · 2022-04 · 24 (2) · 131-136
DOI: 10.1111/tog.12799 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Obstetrician & Gynaecologist, online erschienen am 22.04.2022. Verfasst von Victoria Asfour und 7 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Key content Bilateral salpingo‐oophorectomy is indicated for patients with suspected or confirmed gynaecological malignancy. Risk reduction surgery is indicated in patients with a significant family history or a genetic predisposition to developing breast or ovarian cancer. Bilateral salpingectomy with ovarian conservation reduces the risk of ovarian cancer, whilst preserving ovarian function. Oophorectomy prior to the menopause is associated with increased all‐cause mortality and significant menopause related morbidity. Conservative measures such as weight loss, family planning and lifestyle advice could reduce the overall lifetime risk of ovarian cancer. Learning objectives To understand the rationale of the decision‐making process for bilateral salpingo‐oophorectomy or bilateral salpingectomy with ovarian conversation at the time of hysterectomy for benign disease. To understand the risk–benefit balance of performing oophorectomy in the context of risk reduction of high‐risk patients compared with patients with no genetic predisposition or family history. To consider conservative risk reduction measures that do not involve oophorectomy. Ethical issues In the absence of family history or genetic predisposition to ovarian or breast cancer, is it ethical to perform routine oophorectomy in perimenopausal or even postmenopausal women? Is it ethical to reduce the risk of ovarian cancer while increasing all‐cause mortality and menopause‐related morbidity? Is it ethical to offer bilateral salpingectomy as a female sterilisation procedure?
Zitieren
APA
Asfour, V., Jakes, A. D., McMicking, J., Szetho, W. Z., Sayasneh, A., Diab, Y., Mascarenhas, L., & Rymer, J. (2022). Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease. The Obstetrician & Gynaecologist, 24(2), 131-136. https://doi.org/10.1111/tog.12799
Vancouver
Asfour V, Jakes AD, McMicking J, Szetho WZ, Sayasneh A, Diab Y, et al. Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease. The Obstetrician & Gynaecologist. 2022;24(2):131-136. doi:10.1111/tog.12799
BibTeX
@article{Asfour2022,
author = {Asfour, Victoria and Jakes, Adam D and McMicking, Jess and Szetho, Wei Zian and Sayasneh, Ahmad and Diab, Yasser and Mascarenhas, Lawrence and Rymer, Janice},
title = {Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease},
journal = {The Obstetrician & Gynaecologist},
year = {2022},
volume = {24},
number = {2},
pages = {131--136},
doi = {10.1111/tog.12799}
}
EUVIMED